PKC nu antibody |
|||
20R-2919 | Fitzgerald | 100 ul | EUR 471.6 |
Description: Rabbit polyclonal PKC nu antibody |
Human IgG antibody Laboratories manufactures the jena bioscience nu-1208-5 reagents distributed by Genprice. The Jena Bioscience Nu-1208-5 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Jena Bioscience GmbH. Other Jena products are available in stock. Specificity: Jena Category: Bioscience Group: Nu-1208-5
NU 1025 |
||
Biovision | each | EUR 314.4 |
NU 7026 |
||
BPS Bioscience | 50 mg | EUR 525 |
Description: PARP3 Inhibitor |
Nu 6027 |
||
ApexBio | 10 mg | EUR 211.2 |
Description: NU6027 is a potent inhibitor of cellular ATR activity with the IC50 of 6.7 ?M.The ataxia telangiectasia mutated and Rad3-related kinase (ATR) has a crucial role in the stalled replication forks signalling and DNA damage to cell cycle checkpoints and DNA repair. |
Nu 6027 |
||
ApexBio | 5 mg | EUR 154.8 |
Description: NU6027 is a potent inhibitor of cellular ATR activity with the IC50 of 6.7 ?M.The ataxia telangiectasia mutated and Rad3-related kinase (ATR) has a crucial role in the stalled replication forks signalling and DNA damage to cell cycle checkpoints and DNA repair. |
Nu 6027 |
||
ApexBio | 10 mM (in 1mL DMSO) | EUR 157.2 |
Description: NU6027 is a potent inhibitor of cellular ATR activity with the IC50 of 6.7 ?M.The ataxia telangiectasia mutated and Rad3-related kinase (ATR) has a crucial role in the stalled replication forks signalling and DNA damage to cell cycle checkpoints and DNA repair. |
Nu 6027 |
||
ApexBio | 50 mg | EUR 656.4 |
Description: NU6027 is a potent inhibitor of cellular ATR activity with the IC50 of 6.7 ?M.The ataxia telangiectasia mutated and Rad3-related kinase (ATR) has a crucial role in the stalled replication forks signalling and DNA damage to cell cycle checkpoints and DNA repair. |
NU 1025 |
||
ApexBio | 25 mg | EUR 528 |
Description: Novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP). Ki and IC50 values are 48 and 400 nM respectively. |
4L Bioscint |
|||
NAT1438 | Scientific Laboratory Supplies | 4L | EUR 232.8 |
Thaw Medium 5 |
|||
60182-1 | BPS Bioscience | 100 ml | EUR 140 |
Description: This liquid Cell Thawing Medium is optimized for thawing and plating select BPS Bioscience cell lines, including• Gli Reporter - NIH3T3 Recombinant Cell line (Hedgehog Pathway) #60409 |
Thaw Medium 5 |
|||
60182-2 | BPS Bioscience | 500 ml | EUR 600 |
Description: This liquid Cell Thawing Medium is optimized for thawing and plating select BPS Bioscience cell lines, including• Gli Reporter - NIH3T3 Recombinant Cell line (Hedgehog Pathway) #60409 |
Guanosine 5'-triphosphate (GTP) |
|||
79861-1 | BPS Bioscience | 100 µl | EUR 195 |
Description: Guanosine 5'-triphosphate sodium salt hydrate (GTP) functions as a carrier of phosphates and pyrophosphates involved in channeling chemical energy into specific biosynthetic pathways. |
Guanosine 5'-triphosphate (GTP) |
|||
79861-2 | BPS Bioscience | 500 µl | EUR 650 |
Description: Guanosine 5'-triphosphate sodium salt hydrate (GTP) functions as a carrier of phosphates and pyrophosphates involved in channeling chemical energy into specific biosynthetic pathways. |
Sirtuin 5, GST-tag |
|||
50016 | BPS Bioscience | 100 µg | EUR 440 |
Description: Human Sirtuin 5 (GenBank Accession No. NM_012241), full length with N-terminal GST-tag, MW= 59.8 kDa, expressed in an E. coli expression system. |
Fluorogenic Sirtuin 5 Substrate |
|||
50126 | BPS Bioscience | 250 nmole | EUR 235 |
Description: A fluorogenic, succinylated peptide substrate for Sirtuin 5. This substrate should be used in conjunction with SIRT Developer, #50089. Optimal excitation wavelength 350-380 nm, emission wavelength 440-460 nm. |
Anti-5-caC polyclonal antibody |
|||
25201 | BPS Bioscience | 100 µg | EUR 415 |
Description: Polyclonal antibody raised in rabbit against 5-Carboxylcytosine (5ca-CMP monophosphate) conjugated to BSA |
4x HMT Assay Buffer 5 |
|||
52191 | BPS Bioscience | 30 ml | EUR 210 |
Description: HMT Assay Buffer 5 is optimized for assaying PRMT4/CARM1 using BPS Bioscience's assay kits |
Anti-5-hmC monoclonal antibody (mouse) |
|||
25202 | BPS Bioscience | 50 µg | EUR 415 |
Description: Monoclonal antibody raised in mouse against 5-hydroxymethylcytosine conjugated to BSA |
Anti-5-hmC polyclonal antibody (rabbit) |
|||
25203 | BPS Bioscience | 50 µg | EUR 415 |
Description: Polyclonal antibody raised in rabbit against 5-hydroxymethylcytosine conjugated to KLH. |
Anti-5-hmC polyclonal antibody (rabbit) |
|||
25205 | BPS Bioscience | 100 µl | EUR 415 |
Description: Polyclonal antibody raised in rabbit against 5-hydroxymethylcytosine (5-hmC) conjugated to KLH |
Anti-5-mC monoclonal antibody 33D3 |
|||
25207 | BPS Bioscience | 100 µg | EUR 580 |
Description: Monoclonal antibody raised in mouse against 5-mC (5-methylcytosine) conjugated to ovalbumin. The 5-methylcytosine antibody (clone 33D3) is the most published and widely used antibody for DNA methylation analysis. It has been validated for Methylated DNA Immunoprecipitation (MeDIP-seq, MeDIP-on-chip), Immunofluorescence, Flow Cytometry, Dot blot & ELISA. |
IL-1β (Human) Colorimetric ELISA Detection Kit (5 x 96 rxns) |
|||
79771-2 | BPS Bioscience | 5 x 96 rxns. | EUR 610 |
Description: The cytokine protein Interleukin-1β is a mediator in the inflammatory response and is a therapeutic target for autoinflammatory diseases such as Alzheimer's disease and Schnitzler syndrome. The Colorimetric Human IL-1β Detection Kit is designed for detecting and quantifying human interleukin-1β in cell culture medium. Only a few simple steps on a microtiter plate are required for the assay. First, the capture antibody is coated on a 96-well plate. Next, samples containing IL-1β are incubated on the coated plate followed by detecting the captured IL-1 β with the detection antibody. Finally, the plate is treated with streptavidin-HRP followed by addition of a colorimetric HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader. |
IL-6 (Human) Colorimetric ELISA Detection Kit -5 x 96 reactions |
|||
79820-2 | BPS Bioscience | 5 x 96 rxns. | EUR 610 |
Description: Interleukin-6 is a cytokine produced in response to infections or tissue damage that plays an important role in inflammation, immune response and hematopoiesis. The Colorimetric Human IL-6 Detection Kit is designed for detecting and quantifying human interleukin-6 in cell culture medium. This kit comes in a convenient 96-well format, with capturing and detection antibodies for IL-6, streptavidin-labeled HRP, blocking buffer, IL-6 standard, and colorimetric HRP substrate for a 96-well plate. Only a few simple steps on a microtiter plate are required for the assay. First, the capturing antibody is coated on a 96-well plate. Next, samples containing IL-6 are incubated on the coated plate followed by detecting the captured IL-6 with the detection antibody. Finally, the plate is treated with streptavidin-HRP followed by addition of a colorimetric HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader. |
Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter) |
|||
78651-1 | BPS Bioscience | 100 µl | EUR 875 |
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer protection against the viral infection. Omicron Variant was identified in South Africa in November of 2021. This variant has a large number of mutations that allow the virus to spread more easily and quickly than other variants. As of May 2022, Omicron variants have been divided into seven distinct sub-lineages: BA.1, BA.1.1, BA.2, BA.3, BA.2.12.1, BA.4, and BA.5. Among them, BA.4 and BA.5 have identical mutations on their spike protein. The spike protein of BA.4 and BA.5 are referred as BA.4/5 in this datasheet.The Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1 containing all the Omicron BA.4/5 mutations; see below for details) as the envelope glycoprotein instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by a CMV promoter, therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) pseudovirus can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 Omicron BA.4/5 variant in a Biosafety Level 2 facility.As shown in Figures 2 and 3, the Spike Omicron BA.4/5 pseudovirus has been validated for use with target cells ACE2-HEK293 (which overexpress ACE2; BPS Bioscience #79951).Spike Mutations in BA.4/5, Omicron Variant:Del69-70, T19I, LPPA24-27S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K |
Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter) |
|||
78651-2 | BPS Bioscience | 500 µl x 2 | EUR 4405 |
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer protection against the viral infection. Omicron Variant was identified in South Africa in November of 2021. This variant has a large number of mutations that allow the virus to spread more easily and quickly than other variants. As of May 2022, Omicron variants have been divided into seven distinct sub-lineages: BA.1, BA.1.1, BA.2, BA.3, BA.2.12.1, BA.4, and BA.5. Among them, BA.4 and BA.5 have identical mutations on their spike protein. The spike protein of BA.4 and BA.5 are referred as BA.4/5 in this datasheet.The Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1 containing all the Omicron BA.4/5 mutations; see below for details) as the envelope glycoprotein instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by a CMV promoter, therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (BA.4/5, Omicron Variant) (SARS-CoV-2) pseudovirus can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 Omicron BA.4/5 variant in a Biosafety Level 2 facility.As shown in Figures 2 and 3, the Spike Omicron BA.4/5 pseudovirus has been validated for use with target cells ACE2-HEK293 (which overexpress ACE2; BPS Bioscience #79951).Spike Mutations in BA.4/5, Omicron Variant:Del69-70, T19I, LPPA24-27S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K |